NewLink Genetics Corp (NASDAQ:NLNK)

1.67
Delayed Data
As of 12:58pm ET
 +0.01 / +0.60%
Today’s Change
1.28
Today|||52-Week Range
5.61
+9.87%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close1.66
Today’s open1.66
Day’s range1.63 - 1.68
Volume41,919
Average volume (3 months)477,291
Market cap$58.5M
Data as of 12:58pm ET, 05/21/2019

Growth & Valuation

Earnings growth (last year)+37.34%
Earnings growth (this year)+51.74%
Earnings growth (next 5 years)+15.24%
Revenue growth (last year)-56.55%
P/E ratioNM
Price/Sales4.53
Price/Book0.51

Competitors

 Today’s
change
Today’s
% change
--Verona Pharma PLC-0.00-0.33%
AGRXAgile Therapeutics I...-0.02-1.44%
AQXPAquinox Pharmaceutic...-0.04-1.49%
SCPHScpharmaceuticals In...+0.22+6.49%
Data as of 1:06pm ET, 05/21/2019

Financials

Next reporting dateJuly 29, 2019
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$12.5M
Annual profit (last year)-$53.6M
Net profit margin-429.65%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO &
Chief Scientific Officer
Charles J. Link
President &
Director
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts